Literature DB >> 19669378

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

Shiv Kumar Sarin1, Ashish Kumar, John A Almeida, Yogesh Kumar Chawla, Sheung Tat Fan, Hitendra Garg, H Janaka de Silva, Saeed Sadiq Hamid, Rajiv Jalan, Piyawat Komolmit, George K Lau, Qing Liu, Kaushal Madan, Rosmawati Mohamed, Qin Ning, Salimur Rahman, Archana Rastogi, Stephen M Riordan, Puja Sakhuja, Didier Samuel, Samir Shah, Barjesh Chander Sharma, Praveen Sharma, Yasuhiro Takikawa, Babu Ram Thapa, Chun-Tao Wai, Man-Fung Yuen.   

Abstract

The Asian Pacific Association for the Study of the Liver (APASL) set up a working party on acute-on-chronic liver failure (ACLF) in 2004, with a mandate to develop consensus guidelines on various aspects of ACLF relevant to disease patterns and clinical practice in the Asia-Pacific region. Experts predominantly from the Asia-Pacific region constituted this working party and were requested to identify different issues of ACLF and develop the consensus guidelines. A 2-day meeting of the working party was held on January 22-23, 2008, at New Delhi, India, to discuss and finalize the consensus statements. Only those statements that were unanimously approved by the experts were accepted. These statements were circulated to all the experts and subsequently presented at the Annual Conference of the APASL at Seoul, Korea, in March 2008. The consensus statements along with relevant background information are presented in this review.

Entities:  

Year:  2008        PMID: 19669378      PMCID: PMC2712314          DOI: 10.1007/s12072-008-9106-x

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  81 in total

Review 1.  Acute-on-chronic liver failure: pathophysiological basis of therapeutic options.

Authors:  Rajiv Jalan; Roger Williams
Journal:  Blood Purif       Date:  2002       Impact factor: 2.614

2.  Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome.

Authors:  Li-Min Guo; Jing-Yuan Liu; Dao-Zhen Xu; Bao-Shun Li; Hao Han; Ling-Hang Wang; Wei-Yan Zhang; Lian-He Lu; Xia Guo; Feng-Xia Sun; Hong-Yu Zhang; Xiao-Dong Liu; Jian-Ping Zhang; Yun Yao; Zhong-Ping He; Min-Min Wang
Journal:  Liver Int       Date:  2003       Impact factor: 5.828

3.  Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab.

Authors:  Toshiki Sera; Yoichi Hiasa; Kojiro Michitaka; Ichiro Konishi; Kana Matsuura; Yoshio Tokumoto; Bunzo Matsuura; Takeshi Kajiwara; Toshikazu Masumoto; Norio Horiike; Morikazu Onji
Journal:  Intern Med       Date:  2006-07-03       Impact factor: 1.271

Review 4.  [Acute-on-chronic liver failure].

Authors:  H Ohnishi; J Sugihara; H Moriwaki; Y Muto
Journal:  Ryoikibetsu Shokogun Shirizu       Date:  1995

Review 5.  Fulminant and subfulminant liver failure: definitions and causes.

Authors:  J Bernuau; B Rueff; J P Benhamou
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

6.  Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.

Authors:  G Perceau; N Diris; O Estines; C Derancourt; S Lévy; P Bernard
Journal:  Br J Dermatol       Date:  2006-11       Impact factor: 9.302

7.  Accumulation of symmetric dimethylarginine in hepatorenal syndrome.

Authors:  Paloma Lluch; Maria D Mauricio; José M Vila; Gloria Segarra; Pascual Medina; Juan A Del Olmo; José M Rodrigo; Miguel A Serra
Journal:  Exp Biol Med (Maywood)       Date:  2006-01

8.  Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery.

Authors:  H E Rice; G E O'Keefe; W S Helton; K Johansen
Journal:  Arch Surg       Date:  1997-08

Review 9.  Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Authors:  Holbrook E Kohrt; Daniel L Ouyang; Emmet B Keeffe
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

10.  Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.

Authors:  Paloma Lluch; Belén Torondel; Pascual Medina; Gloria Segarra; Juan A Del Olmo; Miguel A Serra; José M Rodrigo
Journal:  J Hepatol       Date:  2004-07       Impact factor: 25.083

View more
  300 in total

1.  Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis.

Authors:  Vipin Verma; Shiv Kumar Sarin; Praveen Sharma; Ashish Kumar
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure.

Authors:  Li-Yuan Wang; Qing-Hua Meng; Zhi-Qiang Zou; Yu-Chen Fan; Jie Han; Zhao-Xia Qi; Jian Ge; Ai-Ling Xu; Si-Kui Wang; Kai Wang
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

3.  Defining 'acute on chronic liver failure': an identity crisis!

Authors:  Guruprasad P Aithal
Journal:  Indian J Gastroenterol       Date:  2010-10-31

4.  Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis.

Authors:  Philip A Berry; Charalambos G Antoniades; Ivana Carey; Mark J W McPhail; Munther J Hussain; Edward T Davies; Julia A Wendon; Diego Vergani
Journal:  Intensive Care Med       Date:  2010-12-16       Impact factor: 17.440

5.  Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF).

Authors:  Ajay Duseja; Y K Chawla; R K Dhiman; Amit Kumar; Narendra Choudhary; Sunil Taneja
Journal:  Dig Dis Sci       Date:  2010-08-19       Impact factor: 3.199

6.  Score model for predicting acute-on-chronic liver failure risk in chronic hepatitis B.

Authors:  Fang-Yuan Gao; Yao Liu; Xiao-Shu Li; Xie-Qiong Ye; Le Sun; Ming-Fan Geng; Rui Wang; Hui-Min Liu; Xiao-Bing Zhou; Li-Li Gu; Yan-Min Liu; Gang Wan; Xian-Bo Wang
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

7.  Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system.

Authors:  Pi-Qi Zhou; Shao-Ping Zheng; Min Yu; Sheng-Song He; Zhi-Hong Weng
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

8.  Noninvasive measurement of liver fibrosis by transient elastography and influencing factors in patients with chronic hepatitis B-A single center retrospective study of 466 patients.

Authors:  Hongfang Ding; Ting Wu; Ke Ma; Xiaojing Wang; Zeguang Wu; Wei Guo; Junying Qi; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

9.  Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Tianyan Chen; Yingli He; Xiaojing Liu; Zhi Yan; Ke Wang; Hongli Liu; Shuling Zhang; Yingren Zhao
Journal:  Clin Exp Med       Date:  2011-10-15       Impact factor: 3.984

10.  Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.

Authors:  Basile Njei; Thomas R McCarty; Loren Laine
Journal:  J Gastroenterol Hepatol       Date:  2017-04       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.